BTIG Maintains Buy on GeneDx Holdings, Raises Price Target to $200

Benzinga · 1d ago
BTIG analyst Mark Massaro maintains GeneDx Holdings (NASDAQ:WGS) with a Buy and raises the price target from $165 to $200.